Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf

NCT04430374 | Unknown

• 1 other identifier: MRC-05-113
• Study Type: observational
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The novel coronavirus, severe acute respiratory syndrome coronavirus 2, that causes coronavirus disease 2019 (COVID -19), is highly contagious in the community and has resulted in a global pandemic. This infection has a special implication on the patient who complains from cardiac disease or acute cardiovascular condition and may result in cardiovascular complications such as myocardial infarction. For this end, we target to study this group of patient, who has a cardiac disease with COVID-19 in Qatar, in addition, the acute myocardial infarction with COVID-19 from the Gulf countries and collect all the related data to come with a comprehensive view about those patients.

Conditions

Cardiovascular Diseases

Outcome Measures

Primary Outcomes (1)

• The impact of COVID-19 on cardiovascular patient

  The outcome of this registry will be: * entire information about the patients who admitted with COVID-19 accompany with a cardiovascular condition in Qatar. * Additionally, a comparison will be conducted between the cardiac patient who admitted over the period February to December to December 2020 and the same category of patients over the same period of 2019 in Qatar to figure out the reason behind the dropping of the number of the patient. * A multicenter data from the Gulf countries for Acute MI patients infected with COVID-19. * A comparison between our patients (either in Qatar only or the entire Gulf) populations and the outcome of other international registries such as the NACMI (US registry)

  2 month from starting date

Interventions

No interverntion OTHER

No intervention will be done, registry only

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

(1) Retrospective data for all patients since the COVID-19 appear in Qatar unit the prospective arm gets started after approval(2) Prospective data starting from the date of submission of this protocol and forward and all patients will be followed up for long-term outcome(3) Retrospective data for all cardiac patients hospitalizations in the COVID period of this year 2020 will be compared to previous years to report the trends of acute cardiovascular conditions in the COVID era to previous data, as a lot of countries documented decrease in the incidence.

You may qualify if:

• Patients who admitted to the heart hospital or any other hospital with acute cardiovascular condition.
• Patient with confirming or suspicious of COVID-19 infection
• Patient who admitted to any hospital in the Gulf and has Acute MI with confirm or suspicious of COVID-19 infection

You may not qualify if:

• N/A

Sponsors & Collaborators

• Hamad Medical Corporation: lead

Study Sites (1)

Hamad Medical Corporation

Doha, Unlisted (UL), 974, Qatar

RECRUITING

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

• Dr.Jassim Alsuwaidi Senior Consultant

  HMC

  PRINCIPAL INVESTIGATOR

Central Study Contacts

MRC

CONTACT

44396168; MRC@hamad.qa

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 1 Week
• Sponsor Type: INDUSTRY
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Senior Cardiologist

Study Record Dates

• First Submitted: June 11, 2020
• First Posted: June 12, 2020
• Study Start: June 2, 2020
• Primary Completion: December 31, 2020
• Study Completion: December 31, 2020
• Last Updated: June 26, 2020

Record last verified: 2020-06

Locations

QA (1)